{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:47:27Z","timestamp":1791823647719,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cultivation Project of Sichuan Science and Technology Department","award":["2022088"],"award-info":[{"award-number":["2022088"]}]},{"name":"Cultivation Project of Sichuan Science and Technology Department","award":["2022089"],"award-info":[{"award-number":["2022089"]}]},{"name":"Chengdu Medical Research Project","award":["2024090"],"award-info":[{"award-number":["2024090"]}]},{"name":"Technological Innovation Project of Chengdu Science and Technology Department","award":["2024-YF05-00157-SN"],"award-info":[{"award-number":["2024-YF05-00157-SN"]}]},{"name":"Seedling Engineering project of Sichuan Science and Technology Department","award":["2022JDRC0145"],"award-info":[{"award-number":["2022JDRC0145"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84564-0","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T16:08:24Z","timestamp":1736179704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Abnormal ac4C modification in metabolic dysfunction associated steatotic liver cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiqian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"84564_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. Epidemiological features of NAFLD From 1999 to 2018 in China. Hepatology 71, 1851\u20131864 (2020).","journal-title":"Hepatology"},{"key":"84564_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","volume":"18","author":"M Masoodi","year":"2021","unstructured":"Masoodi, M. et al. Metabolomics and lipidomics in NAFLD: Biomarkers and non-invasive diagnostic tests. Nat. Rev. Gastroenterol. Hepatol. 18, 835\u2013856 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"84564_CR3","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537\u20132564 (2021).","journal-title":"Cell"},{"key":"84564_CR4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W. & Rinella, M. Non-alcoholic fatty liver disease. Lancet 397, 2212\u20132224 (2021).","journal-title":"Lancet"},{"key":"84564_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","volume":"22","author":"D Wiener","year":"2021","unstructured":"Wiener, D. & Schwartz, S. The epitranscriptome beyond m(6)A. Nat Rev Genet 22, 119\u2013131 (2021).","journal-title":"Nat Rev Genet"},{"key":"84564_CR6","doi-asserted-by":"crossref","unstructured":"Dominissini D, Rechavi G. Epitranscriptome regulation. Nat Struct Mol Biol 2018.","DOI":"10.1038\/s41594-018-0140-7"},{"key":"84564_CR7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara, S., Ries, R. J. & Jaffrey, S. R. Reading, writing and erasing mRNA methylation. Nat. Rev. Mol. Cell Bio. 20, 608\u2013624 (2019).","journal-title":"Nat. Rev. Mol. Cell Bio."},{"key":"84564_CR8","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango, D. et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell 175, 1872\u201386.e24 (2018).","journal-title":"Cell"},{"key":"84564_CR9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41586-020-2418-2","volume":"583","author":"A Sas-Chen","year":"2020","unstructured":"Sas-Chen, A. et al. Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping. Nature 583, 638\u2013643 (2020).","journal-title":"Nature"},{"key":"84564_CR10","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.cell.2018.11.037","volume":"175","author":"D Dominissini","year":"2018","unstructured":"Dominissini, D. & Rechavi, G. N(4)-acetylation of cytidine in mRNA by NAT10 regulates stability and translation. Cell 175, 1725\u20131727 (2018).","journal-title":"Cell"},{"key":"84564_CR11","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fcell.2020.00842","volume":"8","author":"G Guo","year":"2020","unstructured":"Guo, G. et al. Epitranscriptomic N4-acetylcytidine profiling in CD4(+) T cells of systemic lupus erythematosus. Front Cell Dev Biol 8, 842 (2020).","journal-title":"Front Cell Dev Biol"},{"key":"84564_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.chom.2020.05.011","volume":"28","author":"K Tsai","year":"2020","unstructured":"Tsai, K. et al. Acetylation of cytidine residues boosts HIV-1 gene expression by increasing viral RNA Stability. Cell Host Microbe. 28, 306\u201312.e6 (2020).","journal-title":"Cell Host Microbe."},{"key":"84564_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Xu, W., Zhai, T., You, J. & Chen, Y. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway. Acta Pharm. Sin. B 9, 745\u2013757 (2019).","journal-title":"Acta Pharm. Sin. B"},{"key":"84564_CR14","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"84564_CR15","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/biom12060824","volume":"12","author":"F Nassir","year":"2022","unstructured":"Nassir, F. NAFLD: Mechanisms, treatments, and biomarkers. Biomolecules 12, 824 (2022).","journal-title":"Biomolecules"},{"key":"84564_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2337\/db17-0799","volume":"67","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis. Diabetes 67, 581\u2013593 (2018).","journal-title":"Diabetes"},{"key":"84564_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/00075197-200209000-00014","volume":"5","author":"G Boden","year":"2002","unstructured":"Boden, G. Interaction between free fatty acids and glucose metabolism. Curr. Opin. Clin. Nutr. 5, 545\u2013549 (2002).","journal-title":"Curr. Opin. Clin. Nutr."},{"key":"84564_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/MCO.0b013e328042ba90","volume":"10","author":"J Delarue","year":"2007","unstructured":"Delarue, J. & Magnan, C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. 10, 142\u2013148 (2007).","journal-title":"Curr. Opin. Clin. Nutr."},{"key":"84564_CR19","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1038\/srep05832","volume":"4","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Association between serum free fatty acid levels and nonalcoholic fatty liver disease: A cross-sectional study. Sci. Rep.-Uk 4, 5832 (2014).","journal-title":"Sci. Rep.-Uk"},{"key":"84564_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bbrc.2016.05.124","volume":"476","author":"C Dong","year":"2016","unstructured":"Dong, C. et al. tRNA modification profiles of the fast-proliferating cancer cells. Biochem. Biophys. Res. Commun. 476, 340\u2013345 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"84564_CR21","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.cell.2012.04.031","volume":"149","author":"A Castello","year":"2012","unstructured":"Castello, A. et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149, 1393\u20131406 (2012).","journal-title":"Cell"},{"key":"84564_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115628","volume":"213","author":"J Luo","year":"2023","unstructured":"Luo, J., Cao, J., Chen, C. & Xie, H. Emerging role of RNA acetylation modification ac4C in diseases: Current advances and future challenges. Biochem. Pharmacol. 213, 115628 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"84564_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13046-022-02586-w","volume":"42","author":"M Deng","year":"2023","unstructured":"Deng, M. et al. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression. J. Exp. Clin. Cancer Res. 42, 9 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"84564_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang, G. et al. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin. Transl. Med. 12, e738 (2022).","journal-title":"Clin. Transl. Med."},{"key":"84564_CR25","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng, X. et al. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun. 42, 1347\u20131366 (2022).","journal-title":"Cancer Commun."},{"key":"84564_CR26","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.3390\/genes13122400","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Revealing the potential markers of N(4)-Acetylcytidine through acRIP-seq in triple-negative breast cancer. Genes 13, 2400 (2022).","journal-title":"Genes"},{"key":"84564_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121462","volume":"318","author":"TA Dodson","year":"2023","unstructured":"Dodson, T. A. et al. Ribonucleosides from tRNA in hyperglycemic mammalian cells and diabetic murine cardiac models. Life Sci. 318, 121462 (2023).","journal-title":"Life Sci."},{"key":"84564_CR28","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s42003-022-03868-x","volume":"5","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. NAT10 regulates neutrophil pyroptosis in sepsis via acetylating ULK1 RNA and activating STING pathway. Commun. Biol. 5, 916 (2022).","journal-title":"Commun. Biol."},{"key":"84564_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202106058","volume":"9","author":"K Wang","year":"2022","unstructured":"Wang, K. et al. PIWI-interacting RNA HAAPIR regulates cardiomyocyte death after myocardial infarction by promoting NAT10-mediated ac(4) C acetylation of Tfec mRNA. Adv. Sci. 9, e2106058 (2022).","journal-title":"Adv. Sci."},{"key":"84564_CR30","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3233\/JAD-220564","volume":"90","author":"Y Ma","year":"2022","unstructured":"Ma, Y. et al. Comprehensive analysis of long non-coding RNAs N4-acetylcytidine in Alzheimer\u2019s disease mice model using high-throughput sequencing. J. Alzheimers Dis. 90, 1659\u20131675 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"84564_CR31","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1194\/jlr.M085613","volume":"59","author":"KY Peng","year":"2018","unstructured":"Peng, K. Y. et al. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression. J. Lipid Res. 59, 1977\u20131986 (2018).","journal-title":"J. Lipid Res."},{"key":"84564_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.964337","volume":"10","author":"A Mposhi","year":"2023","unstructured":"Mposhi, A. et al. Mitochondrial DNA methylation in metabolic associated fatty liver disease. Front. Nutr. 10, 964337 (2023).","journal-title":"Front. Nutr."},{"key":"84564_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41598-017-00263-z","volume":"7","author":"MG van der Wijst","year":"2017","unstructured":"van der Wijst, M. G., van Tilburg, A. Y., Ruiters, M. H. & Rots, M. G. Experimental mitochondria-targeted DNA methylation identifies GpC methylation, not CpG methylation, as potential regulator of mitochondrial gene expression. Sci. Rep-Uk 7, 177 (2017).","journal-title":"Sci. Rep-Uk"},{"key":"84564_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology the gene ontology consortium. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"84564_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res"},{"key":"84564_CR36","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"84564_CR37","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1101\/gr.6202607","volume":"17","author":"S Draghici","year":"2007","unstructured":"Draghici, S. et al. A systems biology approach for pathway level analysis. Genome Re 17, 1537\u20131545 (2007).","journal-title":"Genome Re"},{"key":"84564_CR38","doi-asserted-by":"publisher","first-page":"eade7347","DOI":"10.1126\/scitranslmed.ade7347","volume":"16","author":"L Bai","year":"2024","unstructured":"Bai, L. et al. Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progression. Sci. Transl. Med. 16, eade7347 (2024).","journal-title":"Sci. Transl. Med."},{"key":"84564_CR39","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s11033-022-07965-2","volume":"50","author":"J Ding","year":"2023","unstructured":"Ding, J. et al. HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3\/MAPK pathway. Mol. Biol. Rep. 50, 961\u2013970 (2023).","journal-title":"Mol. Biol. Rep."},{"key":"84564_CR40","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1002\/hep.25932","volume":"56","author":"T Matsuzaka","year":"2012","unstructured":"Matsuzaka, T. et al. Elovl6 promotes nonalcoholic steatohepatitis. Hepatology 56, 2199\u20132208 (2012).","journal-title":"Hepatology"},{"key":"84564_CR41","first-page":"E1032","volume":"320","author":"D Xie","year":"2021","unstructured":"Xie, D. et al. High uric acid induces liver fat accumulation via ROS\/JNK\/AP-1 signaling. Am. J. Physiol-Endoc. M 320, E1032\u2013E1043 (2021).","journal-title":"Am. J. Physiol-Endoc. M"},{"key":"84564_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40779-023-00487-3","volume":"10","author":"GH Deng","year":"2023","unstructured":"Deng, G. H. et al. Caveolin-1 is critical for hepatic iron storage capacity in the development of nonalcoholic fatty liver disease. Military Med. Res. 10, 53 (2023).","journal-title":"Military Med. Res."},{"key":"84564_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172910","volume":"871","author":"W Xue","year":"2020","unstructured":"Xue, W. et al. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt\/mTOR pathway. Eur. J. Pharmacol. 871, 172910 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"84564_CR44","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1872-034X.2008.00464.x","volume":"39","author":"H Mitsuyoshi","year":"2009","unstructured":"Mitsuyoshi, H. et al. Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. Hepatol. Res. 39, 366\u2013373 (2009).","journal-title":"Hepatol. Res."},{"key":"84564_CR45","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.161282","volume":"8","author":"T Matsukawa","year":"2023","unstructured":"Matsukawa, T. et al. Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models. JCI Insight 8, e161282 (2023).","journal-title":"JCI Insight"},{"key":"84564_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.780617","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo, Y. et al. Analysis of N6-methyladenosine methylation modification in fructose-induced non-alcoholic fatty liver disease. Front. Endocrinol. 12, 780617 (2021).","journal-title":"Front. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84564-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84564-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84564-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:04:43Z","timestamp":1736183083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84564-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84564"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84564-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1013"}}